fda to stop compounded semaglutide Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # The Risks of Compounded Semaglutide
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 66
GLP-1s are less cost effective than bariatric surgery, and at current prices dont meet most public policy cost-effectiveness thresholds
Semaglutide GLP-1 is a powerful medication that supports weight loss by regulating appetite and helping individuals feel fuller for longer
Clin Pharmacol Ther 37(4):372375
